Icu Medical (ICUI) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Powered by 
Analysis
Icu Medical (ICUI) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -27.18% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 38.54% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 0.98% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | -53.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.80% |
| Mar 31, 2026 | 352.12% |
| Dec 31, 2025 | 44.40% |
| Sep 30, 2025 | 94.38% |
| Jun 30, 2025 | 338.50% |
| Mar 31, 2025 | 59.74% |
| Dec 31, 2024 | -38.96% |
| Sep 30, 2024 | -555.69% |
| Jun 30, 2024 | -46.85% |
| Mar 31, 2024 | -225.35% |
| Dec 31, 2023 | -10.37% |
| Sep 30, 2023 | 154.80% |
| Jun 30, 2023 | -32.91% |
| Mar 31, 2023 | 74.23% |
| Dec 31, 2022 | -177.97% |
| Sep 30, 2022 | -142.50% |
| Jun 30, 2022 | -126.32% |
| Mar 31, 2022 | -260.41% |
| Dec 31, 2021 | -23.78% |
| Sep 30, 2021 | 24.39% |